Literature DB >> 13686753

Excretion of dopamine in diseases of basal ganglia.

A BARBEAU, G F MURPHY, T L SOURKES.   

Abstract

The urinary excretion of catecholamines has been measured in 32 patients with disorders of the basal ganglia. Sixteen patients with Parkinsonism (idiopathic, postencephalitic, and arteriosclerotic types) had a significantly lower amount of dopamine in the urine during a 24-hour period than a group of 24 normal control subjects. In a group of 16 patients with various striatal syndromes the excretion of dopamine and epinephrine was significantly higher than normal. Norepinephrine excretion was similar in the three groups. The lowest mean value of urinary dopamine was found in postencephalitic Parkinsonism; the highest occurred in Wilson's disease.

Entities:  

Keywords:  CATECHOLAMINES/urine; GANGLIA, BASAL/diseases

Mesh:

Substances:

Year:  1961        PMID: 13686753     DOI: 10.1126/science.133.3465.1706-a

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  38 in total

1.  Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1975-06-21       Impact factor: 8.262

2.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

3.  A biochemical study of Huntington's chorea.

Authors:  F E KENYON; S M HARDY
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-04       Impact factor: 10.154

4.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

5.  Proceedings of the International Symposium on "Levodopa: Back to the Future", April 3-4, 2009, Catania, Italy.

Authors: 
Journal:  J Neurol       Date:  2010-11       Impact factor: 4.849

6.  The Biochemistry of Mental Disease.

Authors:  T L Sourkes
Journal:  Can Med Assoc J       Date:  1961-08-26       Impact factor: 8.262

Review 7.  The pharmacology of Parkinson's disease: basic aspects and recent advances.

Authors:  M Da Prada; H H Keller; L Pieri; R Kettler; W E Haefely
Journal:  Experientia       Date:  1984-11-15

8.  Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase.

Authors:  E A Zeller; B Boshes; J Arbit; M Bieber; E R Blonsky; M Dolkart; S V Huprikar
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

9.  The metabolism of orally administered L-Dopa in Parkinsonism.

Authors:  D B Calne; F Karoum; C R Ruthven; M Sandler
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

10.  [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

Authors:  H BERNHEIMER; W BIRKMAYER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1961-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.